Symbol Name ID |
Ampd2
adenosine monophosphate deaminase 2 MGI:88016 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Ampd2m4521Dajl/Ampd2m4521Dajl involves: C3H/HeSnJ * C57BL/6J * SWR |
decreased body weight | J:149088 |
increased circulating cholesterol level | J:149088 | |
increased circulating LDL cholesterol level | J:149088 | |
increased circulating triglyceride level | J:149088 | |
Ampd2tm1b(EUCOMM)Hmgu/Ampd2+ C57BL/6N-Ampd2tm1b(EUCOMM)Hmgu/H |
increased circulating potassium level | J:211773 |
Ampd2tm1b(EUCOMM)Hmgu/Ampd2tm1b(EUCOMM)Hmgu C57BL/6N-Ampd2tm1b(EUCOMM)Hmgu/H |
preweaning lethality, incomplete penetrance | J:211773 |
Ampd2tm1Tm/Ampd2tm1Tm B6.129S2-Ampd2tm1Tm |
abnormal renal tubule morphology | J:196782 |
increased urine protein level | J:196782 | |
podocyte foot process effacement | J:196782 | |
Ampd2tm1Tm/Ampd2tm1Tm involves: 129S2/SvPas |
normal immune system phenotype | J:201211 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 06/12/2024 MGI 6.13 |
![]() |
|